Venous Thromboembolic Events after Total Knee Arthroplasty: Which Patients Are at a High Risk?

Abstract

Venous thromboembolism (VTE; deep venous thrombosis and pulmonary embolism) is a known complication following primary total knee arthroplasty (TKA). The aim of this study was to investigate the trends of the incidence of VTE after primary TKA and identify associated risk factors for the occurrence of VTEs in a large cohort of TKA patients. We performed a retrospective study in which the Nationwide Inpatient Sample (NIS) database was used to identify all patients who underwent primary TKA over a period of 13 consecutive years (between 2002 and 2014) in the United States. The occurrence of a symptomatic VTE was identified with the use of ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) diagnosis codes. A total of 1,460,901 primary TKA procedures were identified in the NIS from 2002 to 2014, and 12,944 of these patients were recorded as having 13,855 VTEs, consisting of 7,609 deep venous thromboses (0.52%) and 6,246 pulmonary emboli (0.43%). The overall VTE incidence in patients undergoing TKA in the United States from 2002 to 2014 was 0.89%. Patient-related risk factors for VTEs include an older age (odds ratio [OR]: 1.44; 95% confidence interval [CI]: 1.31–1.59), black race (OR: 1.34; 95% CI: 1.25–1.44), and Medicare insurance (OR: 1.18; 95% CI: 1.13–1.22). Most of the comorbidities were associated with an increased risk of VTE following TKA. Particularly, cardiac arrhythmias, coagulopathy, fluid and electrolyte disorders, pulmonary circulation disorders, and weight loss increased the risk of VTE by more than twofold. After adjusting for confounders, VTE was associated with a longer hospital stay (2.81 ± 0.02 day), increased costs (US$14,212.16 ± US$255.64), and higher mortality rate (OR: 13.04; 95% CI: 11.08–15.35). This nationally representative study of inpatients in the United States identified several independent risk factors for VTE perioperatively in TKA patients and provided evidence that VTE patients after TKA are likely to have worse results than non-VTE patients with regard to the length of hospital stay, hospital costs, and inhospital mortality. This is a level III, prognostic study.

Keywords

venous thromboembolic events - total knee arthroplasty - risk factors

Authors' Contributions

W. L. D. participated in the design, collected data, performed statistical analyses, and drafted the manuscript. Z. J. S. collected data and assisted with statistical analyses. Z. M. L. collected and interpreted data and helped draft the manuscript. J. W. conceived the study, participated in the design, and helped draft the manuscript. All of the authors have read and approved the final manuscript.

^* The authors contributed equally to this work.

Publikationsverlauf

Eingereicht: 24. September 2018

Angenommen: 05. April 2019

Artikel online veröffentlicht:
24. Mai 2019

• References

• 1 Colwell CW. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty. Orthopedics 2009; 32 (12) , Suppl): 67-73
• 2 Kirksey M, Chiu YL, Ma Y. , et al. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg 2012; 115 (02) 321-327
• 3 Deitelzweig S. Preventing venous thromboembolic events after total hip arthroplasty: new developments in clinical practice. Hosp Pract (1995) 2012; 40 (02) 79-87
• 4 O'Reilly RF, Burgess IA, Zicat B. The prevalence of venous thromboembolism after hip and knee replacement surgery. Med J Aust 2005; 182 (04) 154-159
• 5 Guyatt GH, Eikelboom JW, Gould MK. , et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e185S-e194S
• 6 Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplasty 2017; 32 (04) 1063-1066
• 7 Falck-Ytter Y, Francis CW, Johanson NA. , et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e278S-e325S
• 8 Zhang ZH, Shen B, Yang J, Zhou ZK, Kang PD, Pei FX. Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years. BMC Musculoskelet Disord 2015; 16: 24
• 9 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e227S-e277S
• 10 Healthcare Cost and Utilization Project (HCUP). Nationwide Inpatient Sample (NIS). Rockville, MD: Agency for Healthcare Research and Quality; 2018
• 11 Healthcare Cost and Utilization Project (HCUP). HCUP Comorbidity Software. Agency for Healthcare Research and Quality; 2002. –2014. Accessed June 30, 2018 http://www.hcup-us.ahrq.gov/nisoverview.jsp
• 12 van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47 (06) 626-633
• 13 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90 (03) 446-455
• 14 White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158 (14) 1525-1531
• 15 Della Valle CJ, Steiger DJ, DiCesare PE. Duplex ultrasonography in patients suspected of postoperative pulmonary embolism following total joint arthroplasty. Am J Orthop 2003; 32 (08) 386-388
• 16 Schwarcz TH, Matthews MR, Hartford JM. , et al. Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used. Ann Vasc Surg 2004; 18 (02) 193-198
• 17 Lewis CG, Inneh IA, Schutzer SF, Grady-Benson J. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution. J Bone Joint Surg Am 2014; 96 (16) 1327-1332
• 18 Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does “excessive” anticoagulation predispose to periprosthetic infection?. J Arthroplasty 2007; 22 (06) (Suppl. 02) 24-28
• 19 Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 2007; 89 (01) 33-38
• 20 Sachs RA, Smith JH, Kuney M, Paxton L. Does anticoagulation do more harm than good?: a comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty. J Arthroplasty 2003; 18 (04) 389-395
• 21 Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004; 86-A [phone]
• 22 Hervey SL, Purves HR, Guller U, Toth AP, Vail TP, Pietrobon R. Provider volume of total knee arthroplasties and patient outcomes in the HCUP-Nationwide Inpatient Sample. J Bone Joint Surg Am 2003; 85-A [phone]
• 23 Kreder HJ, Grosso P, Williams JI. , et al. Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg 2003; 46 (01) 15-22
• 24 Goz V, McCarthy I, Weinreb JH. , et al. Venous thromboembolic events after spinal fusion: which patients are at high risk?. J Bone Joint Surg Am 2014; 96 (11) 936-942
• 25 Steuer CE, Behera M, Kim S. , et al. Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: a Nationwide Inpatient Sample database analysis. Lung Cancer 2015; 88 (01) 80-84